Behrang Shiri Varnamkhasti
Overview
Explore the profile of Behrang Shiri Varnamkhasti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Khoeeniha M, Esfandyari-Manesh M, Behrouz H, Amini M, Shiri Varnamkhasti B, Atyabi F, et al.
Curr Drug Deliv
. 2016 Nov;
14(8):1120-1129.
PMID: 27875950
Background: Cabazitaxel (CBZ) is a new taxane approved by FDA for treatment of castration- resistant prostate cancer not responding to docetaxel. However, CBZ is not a suitable substrate for p-glycoprotein...
12.
Azhdarzadeh M, Atyabi F, Saei A, Shiri Varnamkhasti B, Omidi Y, Fateh M, et al.
Colloids Surf B Biointerfaces
. 2016 Mar;
143:224-232.
PMID: 27015647
Favorable physiochemical properties and the capability to accommodate targeting moieties make superparamegnetic iron oxide nanoparticles (SPIONs) popular theranostic agents. In this study, we engineered SPIONs for magnetic resonance imaging (MRI)...
13.
Behrouz H, Esfandyari-Manesh M, Khoeeniha M, Amini M, Shiri Varnamkhasti B, Atyabi F, et al.
Chem Biol Drug Des
. 2016 Feb;
88(2):230-40.
PMID: 26913996
Recently, it is suggested that mTOR signaling pathway is an important mediator in many cancers especially breast cancer. Therefore, effects of sirolimus as a mTOR inhibitor in breast cancer have...
14.
Panahi Y, Darvishi B, Ghanei M, Jowzi N, Beiraghdar F, Shiri Varnamkhasti B
Cytokine Growth Factor Rev
. 2016 Jan;
28:21-9.
PMID: 26774676
NF-κB pathway has long been considered as one of the potent prototypical pro-inflammatory signaling pathway and its role in several aspects of human health has been established. Recent studies have...
15.
Shiri Varnamkhasti B, Hosseinzadeh H, Azhdarzadeh M, Vafaei S, Esfandyari-Manesh M, Mirzaie Z, et al.
Int J Pharm
. 2015 Aug;
494(1):430-44.
PMID: 26315125
Nanoparticles have been considered to improve delivery and physicochemical characteristics of bioactive agents in recent years. In this study, a core-shell chitosan nanoparticulate system was prepared for the targeted delivery...